← Back to All US Stocks

ACBM Stock Analysis - ACRO BIOMEDICAL CO., LTD. AI Rating

ACBM OTC Services-Amusement & Recreation Services NV CIK: 0001622996
Analysis Date: Mar 19, 2026 | Data as of: 2025-12-31
AI Rating
STRONG SELL
95% Confidence

Investment Thesis

ACBM is in critical financial distress with zero revenue, negative stockholders' equity of -$387K, and unsustainable cash burn of -$196.3K in operating cash flow. The company's negative working capital (0.04x current ratio) and negative ROA of -717.4% indicate severe operational and financial deterioration with minimal viable asset base of only $14.1K against $326.9K in liabilities.

ACBM Strengths

  • + Minimal long-term debt obligations
  • + Company still maintains some cash position ($4.1K)
  • + Public company status allows for potential restructuring options

ACBM Risks

  • ! Zero revenue generation with no apparent business operations
  • ! Negative stockholders' equity indicating technical insolvency
  • ! Liabilities exceed assets by $312.8K creating default risk
  • ! Negative operating cash flow of -$196.3K unsustainable long-term
  • ! Current ratio of 0.04x indicates inability to meet short-term obligations
  • ! No insider buying activity suggesting lack of management confidence

Key Metrics to Watch

ACBM Financial Metrics

Revenue
$0.0
Net Income
$-101.1K
EPS (Diluted)
$0.00
Free Cash Flow
$-196.3K
Total Assets
$14.1K
Cash Position
$4.1K

ACBM Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA -717.4%
FCF Margin N/A

ACBM Balance Sheet & Liquidity

Current Ratio
0.04x
Quick Ratio
-0.70x
Debt/Equity
N/A
Debt/Assets
2,319.1%
Interest Coverage
-48.04x
Long-term Debt
N/A
Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 19, 2026 | Data as of: 2025-12-31 | Powered by Claude AI